Skip to main content
. 2022 Aug 3;15(12):2228–2236. doi: 10.1093/ckj/sfac176

Table 1.

Selected characteristics of study participants stratified by presence or absence of CKD

Characteristics Total CKD Non-CKD P-value
Participants, n 9 461 631 88 271 9 373 360
Demographics
 Age (years), mean (SD) 41.1 (13.3) 64.2 (14.1) 40.9 (13.1) <.001
 Female, n (%) 4 402 939 (46.5) 41 651 (47.2) 4 361 288 (46.5) <.001
 Live in the north, n (%) 3 806 293 (40.2) 31 754 (36.0) 3 774 539 (40.3) <.001
Prior diseases, n (%)
 Diabetes 467 410 (5.11) 14 663 (16.8) 452 747 (5.00) <.001
 Hypertension 1 922 436 (21.9) 47 290 (56.0) 1 875 146 (21.6) <.001
 CVD 52 693 (0.72) 3040 (4.63) 49 653 (0.69) <.001
Metabolic risk factors, mean (SD)
 Systolic BP (mmHg) 123 (18.1) 140 (22.8) 123 (18.0) <.001
 Diastolic BP (mmHg) 75.2 (12.0) 79.7 (13.6) 75.2 (12.0) <.001
 Heart rate (bpm) 73.0 (9.16) 73.2 (10.1) 73.0 (9.15) <.001
 BMI (kg/m2) 24.0 (3.62) 24.9 (3.42) 23.9 (3.62) <.001
 LDL (mmol/l) 2.70 (0.82) 2.90 (0.92) 2.70 (0.82) <.001
 HDL (mmol/l) 1.36 (0.34) 1.37 (0.36) 1.36 (0.34) <.001
 TC (mmol/l) 4.80 (0.98) 5.14 (1.14) 4.79 (0.97) <.001
 TG (mmol/l) 1.53 (1.25) 1.83 (1.36) 1.52 (1.24) <.001
 Fasting glucose (mg/dl) 5.16 (1.24) 5.75 (1.83) 5.16 (1.23) <.001
Kidney function, mean (SD)
 UA (µmol/l) 331 (95.0) 399 (113) 330 (94.6) <.001
 Creatinine (µmol/l) 69.4 (18.3) 124 (72.9) 68.8 (16.1) <.001
 eGFR (ml/min/1.73 m2) 106 (17.9) 51.2 (9.86) 106 (17.2) <.001
 Proteinuria, n (%)a 120 196 (1.36) 11 088 (13.6) 109 108 (1.25) <.001

CKD was defined as an eGFR <60 ml/min/1.73 m2.

Hypertension was defined as systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg or a self-reported history of hypertension.

Diabetes was defined as fasting glucose ≥7.0 mmol/l or haemoglobin A1c ≥6.5% or a self-reported history of diabetes.

CVD was defined as a self-reported history of coronary heart disease.

Proteinuria was defined as a total urinary protein concentration >1 g/l (++ or more).